Services

Market access and reimbursement for pharma, MedTech and digital health

For market access and executive leads in pharma, MedTech and digital health. We develop reimbursement pathways and market access strategy, define pricing, model business case scenarios and plan launch and commercialisation. As consultant or implementation partner, depending on the starting position.

45-minute initial call on Teams, no obligation.

01

Services at a glance

Strategy, reimbursement and commercialisation from a single source.

Reimbursement pathways and market access strategy
Pricing definition
Business case scenarios and growth planning
Market and positioning strategy
Regulatory classification (MDR, DiGA, AI Act)
Launch and commercialisation planning
02

Reimbursement pathways for medical software

The right pathway depends on medical purpose, target group, care context, evidence base and regulatory classification.

Hospital reimbursement via DRG, supplementary payment or NUB structures
Listing in the medical aids directory
Selective contracts with health insurers
Listing as a DiGA or DiPA
Individual care or licence models with healthcare providers

FAQ

Frequently Asked Questions

Get in touch

Schedule a no-obligation initial conversation and find out how we can concretely support your initiative.

See all services